Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of high dosages of
Coenzyme Q10 in slowing clinical decline in people who have early Parkinson disease.
Phase:
Phase 3
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) University of Rochester
Treatments:
alpha-Tocopherol Coenzyme Q10 Tocopherols Tocotrienols Ubiquinone Vitamin E Vitamins